Genocea Biosciences Company

Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.

Last Funding Type: Post-IPO Equity
Funding Status: IPO
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2006-01-01
Last Funding Date: 2020-07-22
Total Funding: 470569774
Employee Number: 51-100
Estimated Revenue: $10M to $50M
Investors Number: 13
Industry: Atrificial Vectors and Immune Cells